Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$713 Mln
Revenue (TTM)
$1,060 Mln
Net Profit (TTM)
$0 Mln
ROE
-0 %
ROCE
-- %
P/E Ratio
--
P/B Ratio
1.3
Industry P/E
--
EV/EBITDA
19.8
Div. Yield
0 %
Debt to Equity
0.9
Book Value
$10.5
EPS
$-0.1
Face value
--
Shares outstanding
50,723,245
CFO
$333.00 Mln
EBITDA
$641.90 Mln
Net Profit
$192.10 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Enhabit Inc (EHAB)
| 51.8 | 2.9 | 51.8 | 60.6 | 0.2 | -- | -- |
|
BSE Sensex
| -13.4 | -9.8 | -13.9 | -3.6 | 7.5 | 7.9 | 11.2 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
|---|---|---|---|
|
Enhabit Inc (EHAB)
| 18.1 | -24.4 | -21.4 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Enhabit Inc (EHAB)
|
14.0 | 712.7 | 1,060.0 | -4.6 | 6.0 | -0.9 | -- | 1.3 |
| 14.0 | 3,186.8 | 3,125.0 | -262.7 | 0.9 | -313.2 | -- | 20.5 | |
| 380.6 | 5,278.0 | 2,530.0 | 265.2 | 14.2 | 25.3 | 20.1 | 5.3 | |
| 54.5 | 2,778.6 | 941.5 | 105.7 | 14.5 | 29.4 | 26.2 | 7.3 | |
| 97.4 | 9,812.1 | 5,935.2 | 566.2 | 18.1 | 25.1 | 17.6 | 3.9 | |
| 19.1 | 4,280.7 | 2,347.6 | 128.4 | 4.5 | 25.2 | 36.8 | 7.9 | |
| 27.5 | 4,285.8 | 5,649.5 | 207.6 | 7.0 | 15.2 | 21.3 | 3.3 | |
| 54.8 | 4,326.1 | 2,040.2 | -18.7 | 5.0 | -1.9 | -- | 4.0 | |
| 15.0 | 3,768.2 | 1,163.6 | 78.0 | 26.1 | 15.4 | 49.1 | 6.2 | |
| 196.6 | 11,646.4 | 5,057.8 | 344.0 | 9.2 | 16.9 | 34.4 | 5.2 |
Enhabit, Inc. provides home health and hospice services in the United States. The Home Health segment offers nursing care; physical, occupational, and speech therapy; medical and social work; and home health aide services. This segment also provides... patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care, and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery or injury, and respiratory diseases; and counseling for patients and their families regarding financial, personal, and social concerns that arise from a patient's health-related problems. Its Hospice segment offers nursing care; pain and symptom management; palliative and dietary counseling; social worker visits; spiritual counseling; and family member bereavement counseling to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was founded in 1998 and is headquartered in Dallas, Texas. Address: 6688 North Central Expressway, Dallas, TX, United States, 75206 Read more
President, CEO & Director
Ms. Barbara Ann Jacobsmeyer B.S., M.A., P.T.
President, CEO & Director
Ms. Barbara Ann Jacobsmeyer B.S., M.A., P.T.
Headquarters
Dallas, TX
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of Enhabit Inc (EHAB) is $14.00 (NYSE) as of 02-Apr-2026 16:00 EDT. Enhabit Inc (EHAB) has given a return of 0.22% in the last 3 years.
Since, TTM earnings of Enhabit Inc (EHAB) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
-101.62
|
0.88
|
|
2024
|
-2.51
|
0.75
|
|
2023
|
-6.43
|
0.77
|
|
2022
|
-16.22
|
0.88
|
|
2021
|
--
|
--
|
The 52-week high and low of Enhabit Inc (EHAB) are Rs 14.22 and Rs 6.47 as of 03-Apr-2026.
Enhabit Inc (EHAB) has a market capitalisation of $ 713 Mln as on 31-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Enhabit Inc (EHAB), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
$0.03
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.